Citigroup’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-163,449
| Closed | -$16.3K | – | 5933 |
|
|
2025
Q4 | $16.3K | Buy |
163,449
+156,608
| +2,289% | +$99.5K | ﹤0.01% | 4919 |
|
|
2025
Q3 | $4.14K | Sell |
6,841
-603
| -8% | -$284 | ﹤0.01% | 5284 |
|
|
2025
Q2 | $2.32K | Sell |
7,444
-68,393
| -90% | -$26.5K | ﹤0.01% | 5355 |
|
|
2025
Q1 | $37.1K | Sell |
75,837
-4,008
| -5% | -$2.36K | ﹤0.01% | 4960 |
|
|
2024
Q4 | $68.4K | Buy |
79,845
+10,178
| +15% | +$63.8K | ﹤0.01% | 4988 |
|
|
2024
Q3 | $592K | Buy |
69,667
+48,488
| +229% | +$286K | ﹤0.01% | 3622 |
|
|
2024
Q2 | $98.9K | Sell |
21,179
-97,625
| -82% | -$462K | ﹤0.01% | 4215 |
|
|
2024
Q1 | $808K | Sell |
118,804
-101,122
| -46% | -$454K | ﹤0.01% | 3194 |
|
|
2023
Q4 | $737K | Buy |
219,926
+153,950
| +233% | +$383K | ﹤0.01% | 3099 |
|
|
2023
Q3 | $164K | Buy |
+65,976
| New | +$109K | ﹤0.01% | 3754 |
|
|
2023
Q2 | – | Sell |
-353,138
| Closed | -$286K | – | 5563 |
|
|
2023
Q1 | $286K | Buy |
353,138
+352,845
| +120,425% | +$348K | ﹤0.01% | 3522 |
|
|
2022
Q4 | $223 | Sell |
293
-101,652
| -100% | -$80.4K | ﹤0.01% | 5590 |
|
|
2022
Q3 | $95K | Buy |
101,945
+92,868
| +1,023% | +$111K | ﹤0.01% | 4113 |
|
|
2022
Q2 | $9K | Buy |
9,077
+6,276
| +224% | +$10.3K | ﹤0.01% | 5388 |
|
|
2022
Q1 | $6K | Sell |
2,801
-2,702
| -49% | -$7.24K | ﹤0.01% | 5735 |
|
|
2021
Q4 | $49K | Buy |
5,503
+1,821
| +49% | +$23.9K | ﹤0.01% | 5068 |
|
|
2021
Q3 | $61K | Buy |
3,682
+585
| +19% | +$10.1K | ﹤0.01% | 4634 |
|
|
2021
Q2 | $64K | Buy |
3,097
+1,081
| +54% | +$20.5K | ﹤0.01% | 4693 |
|
|
2021
Q1 | $38K | Sell |
2,016
-1,820
| -47% | -$39.3K | ﹤0.01% | 4851 |
|
|
2020
Q4 | $85K | Buy |
3,836
+2,047
| +114% | +$42.6K | ﹤0.01% | 5655 |
|
|
2020
Q3 | $37K | Sell |
1,789
-139,848
| -99% | -$3.64M | ﹤0.01% | 5771 |
|
|
2020
Q2 | $5.12M | Buy |
141,637
+137,774
| +3,567% | +$5.77M | ﹤0.01% | 1839 |
|
|
2020
Q1 | $126K | Buy |
3,863
+2,541
| +192% | +$103K | ﹤0.01% | 5153 |
|
|
2019
Q4 | $36K | Buy |
1,322
+1,233
| +1,385% | +$21.1K | ﹤0.01% | 6577 |
|
|
2019
Q3 | $1K | Buy |
+89
| New | +$840 | ﹤0.01% | 7593 |
|
Citigroup's APLT Position: Q1 2026 in Review
Citigroup sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 163,449 shares — an estimated $16.3K sold.
Citigroup first reported a position in APLT in Q3 2019 and held it in 25 quarters. The position peaked at $5.12M in Q2 2020. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Citigroup reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 163,449 Applied Therapeutics shares in Q1 2026, an estimated $16.3K.
- Citigroup first reported a position in Applied Therapeutics in Q3 2019 and held it in 25 quarters.
- Citigroup's Applied Therapeutics position peaked at $5.12M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.